Vaccine Info

Pneumococcal Vaccines

Pneumococcal disease is caused by Streptococcus pneumoniae, a bacterium that has more than 90 serotypes. Only a few of these serotypes produce the majority of invasive pneumococcal disease.

Pneumococcal disease is spread from person to person by droplets in the air. The pneumococci bacteria are common inhabitants of the human respiratory tract.

Pneumococcal pneumonia is the most common disease caused by pneumococcal infection and can occur in combination with bacteremia and/or meningitis, or it can occur alone. 

Isolated pneumococcal pneumonia is not considered an invasive disease, but it can be severe. It is estimated that 175,000 cases occur each year in the USA. The fatality rate is 5-7 percent and could be much higher in the elderly, says the CDC.

Globally, pneumococcal pneumonia is estimated to cause about 500,000 deaths and 30 million episodes in adults 70 years and older annually.

Pneumococcal Vaccine Discounts

Vaccine discounts can be found here sponsored by GoodRx

Pneumococcal Vaccines

  • Pneumovax 23: is a vaccine that protects against infection by 23 types of pneumococcal bacteria, which are common and often cause serious illnesses.
  • Prevnar 13: is a vaccine that protects against invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F
  • 20vPnC (PF-06482077): is a 20-Valent pneumococcal conjugate vaccine candidate to help protect from a substantial invasive pneumococcal disease and pneumonia burden. 

Pneumococcal Vaccine Clinical Trials

Pneumococcal vaccine clinical trial patient recruitment programs are sponsored by Antidote.

Pneumococcal Pneumonia Research News

August 10, 2020 - Study: Factors associated with pneumococcal vaccination uptake by cancer survivors.

July 31, 2020 - Can Flu and Pneumonia Vaccines Prevent Alzheimer’s Disease.

July 28, 2020 - The protective effect of pneumococcal vaccination on cardiovascular disease in adults: A systematic review and meta-analysis.

July 27, 2020 - Influenza and pneumonia vaccinations are associated with reduced risk of Alzheimer's disease, according to new research reported at the Alzheimer's Association International Conference 2020.

July 20, 2020 - Invasive pneumococcal disease incidence in children and adults in France during the pneumococcal conjugate vaccine era: an interrupted time-series analysis of data from a 17-year national prospective surveillance study.

July 15, 2020 - Serum Institute became the first research institute in India to manufacture a domestically developed, fully indigenously developed pneumococcal vaccine.

July 13, 2020 - The risk for invasive pneumococcal disease is increased when contracting influenza, but could be lessened in environments of high humidity, according to a study involving approximately 20,000 individuals in 3 countries, reported JAMA.

January 23, 2020 - Exposure to diesel exhaust particles linked to pneumococcal disease susceptibility.

Pneumococcal Indication

Pneumococcal Vaccines are indicated to prevent pneumococcal pneumonia that is the most common disease caused by a pneumococcal infection and can occur in combination with bacteremia and/or meningitis, or it can occur alone. 

Updated
08/11/2020 - 17:24